Testis-specific serine kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Magdalena Delgado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
Cancer testis antigens (CTAs) are a collection of proteins whose expression is normally restricted to the gamete but abnormally activated in a wide variety of tumors. The CTA, Testis-specific serine kinase 6 (TSSK6), is essential for male fertility in mice. The functional relevance of TSSK6 to cancer, if any, has not previously been investigated. Here we find that TSSK6 is frequently anomalously expressed in colorectal cancer and patients with elevated TSSK6 expression have reduced relapse-free survival. Depletion of TSSK6 from colorectal cancer cells attenuates anchorage-independent growth, invasion, and growth in vivo. Conversely, overexpression of TSSK6 enhances anchorage independence and invasion in vitro as well as in vivo tumor growth. Notably, ectopic expression of TSSK6 in semi-transformed human colonic epithelial cells is sufficient to confer anchorage independence and enhance invasion. In somatic cells, TSSK6 co-localizes with and enhances the formation of paxillin and tensin-positive foci at the cell periphery, suggesting a function in focal adhesion formation. Importantly, TSSK6 kinase activity is essential to induce these tumorigenic behaviors. Our findings establish that TSSK6 exhibits oncogenic activity when abnormally expressed in colorectal cancer cells. Thus, TSSK6 is a previously unrecognized intervention target for therapy, which could exhibit an exceptionally broad therapeutic window.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas, USA.
- Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas, USA. Electronic address: angelique.whitehurst@utsouthwestern.edu.
Förderung
- NCI NIH HHS
- National Cancer Institute
- Cancer Prevention and Research Institute of Texas
- Welch Foundation
- National Institute on Drug Abuse
- National Heart, Lung, and Blood Institute
- National Institutes of Health
- National Institute of Mental Health
Zitieren
APA
Delgado, M., Gallegos, Z., Stippec, S., McGlynn, K., Cobb, M. H., & Whitehurst, A. W. (2024). Testis-specific serine kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107380
Vancouver
Delgado M, Gallegos Z, Stippec S, McGlynn K, Cobb MH, Whitehurst AW. Testis-specific serine kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107380
BibTeX
@article{Delgado2024,
author = {Delgado, Magdalena and Gallegos, Zachary and Stippec, Steve and McGlynn, Kathleen and Cobb, Melanie H and Whitehurst, Angelique W},
title = {Testis-specific serine kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107380}
}
EUVIMED